Abstract
Introduction
The interrelationship between neurocognitive impairments and motor functions was observed in patients with advanced Parkinson’s disease (PD). This study was conducted to identify pre-operative neurocognitive and clinical predictors of short-term motor outcome following subthalamic nucleus deep brain stimulation (STN-DBS).
Methods
All consecutive PD patients who were eligible for bilateral STN-DBS from 2009 to 2019 were evaluated before and at 1 year following surgery. Standard motor evaluation and neurocognitive tests including global cognition, memory, executive functions (attention and category fluency), confrontational speech, visuospatial abilities, and mood were conducted at baseline. The post-operative STN-DBS effects were assessed at 1 year following the surgery. Multiple regression analysis was applied to identify baseline independent predictors of post-operative STN-DBS effect.
Results
A total of 82 patients were analyzed. It was found that younger age at operation, higher levodopa responsiveness at baseline based on UPDRS-III total score, and better baseline verbal delayed memory and category fluency predicted post-operative motor outcome at 1 year following STN-DBS (F = 9.639, p < 0.001, R2 = .340).
Conclusion
Our findings demonstrated the role of baseline cognitive burden, especially cognitive processes related to frontostriatal circuits, was significant clinical predictors of short-term motor outcomes following STN-DBS. Profile analysis of neurocognitive functions at baseline is recommended.
Similar content being viewed by others
References
Benabid A-L, Deuschl G, Lang AE, Lyons KE, Rezai AR (2006) Deep brain stimulation for Parkinson’s disease. Mov Disord 21(S14):S168–S170
Zhu XL, Chan DT, Lau CK, Poon WS, Mok VC, Chan AY, Wong LK, Yeung JH, Leung MC, Tang VY, Wong RK, Yeung C (2014) Cost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: a prospective study. World Neurosurg 82(6):987–993
Saranza G, Lang AE (2021) Levodopa challenge test: indications, protocol, and guide. J Neurol. 268(9):3135–3143. https://doi.org/10.1007/s00415-020-09810-7
Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G (2006) Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21(Suppl 14):S290-304
Fukaya C, Watanabe M, Kobayashi K, Oshima H, Yoshino A, Yamamoto T (2017) Predictive factors for long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease. Neurol Med Chir (Tokyo) 57(4):166–171
Lin Z, Zhang X, Wang L, Zhang Y, Zhou H, Sun Q, Sun B, Huang P, Li D (2021) Revisiting the L-Dopa response as a predictor of motor outcomes after deep brain stimulation in Parkinson’s disease. Front Hum Neurosci. 4(15):604433. https://doi.org/10.3389/fnhum.2021.604433
Cavallieri F, Fraix V, Bove F, Mulas D, Tondelli M, Castrioto A, Krack P, Meoni S, Schmitt E, Lhommée E, Bichon A, Pélissier P, Chevrier E, Kistner A, Seigneuret E, Chabardès S, Moro E (2021) Predictors of Long-term outcome of subthalamic stimulation in Parkinson disease. Ann Neurol 89(3):587–597
Santangelo G, Vitale C, Picillo M, Moccia M, Cuoco S, Longo K, Pezzella D, di Grazia A, Erro R, Pellecchia MT, Amboni M, Trojano L, Barone P (2015) Mild cognitive impairment in newly diagnosed Parkinson’s disease: a longitudinal prospective study. Parkinsonism Relat Disord 21(10):1219–1226
Luca A, Monastero R, Baschi R, Cicero CE, Mostile G, Davì M, Restivo V, Zappia M, Nicoletti A (2021) Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort. Sci Rep 11(1):867
Camicioli R, Majumdar SR (2010) Relationship between mild cognitive impairment and falls in older people with and without Parkinson’s disease: 1-year prospective cohort study. Gait Posture 32(1):87–91
Smeding HMM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B (2011) Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s disease. J Neurol Neurosurg Psychiatry 82(7):754–760
Grill WM (2005) Safety considerations for deep brain stimulation: review and analysis. Expert Rev Med Devices 2(4):409–420
Kwan V, Shum D, Haffenden A, Yeates KO, Kwok A, Lau H, Poon WS, Chan D, Zhu XL, Chan D, Mok V, Chan A, Ma K, Yeung J, Lau C, Bezchlibnyk Y, Kiss Z, Tang V (2021) A retrospective comparison of cognitive performance in individuals with advanced Parkinson’s Disease in Hong Kong and Canada. Appl Neuropsychol Adult 15:1–9. https://doi.org/10.1080/23279095.2021
Wong A, Law LS, Liu W, Wang Z, Lo ES, Lau A, Wong LK, Mok VC (2015) Montreal Cognitive Assessment: one cutoff never fits all. Stroke 46(12):3547–3550
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356
Lee TMC, Wing K (2010) Neuropsychological measures: normative data for Chinese, second edition (revised). The University of Hong Kong, Hong Kong
Benton AS (1991) Benton Visual Retention Test, 5th edn. The Psychological Corporation, San Antonio, Texas, Manual
Cheung RW, Cheung MC, Chan AS (2004) Confrontation naming in Chinese patients with left, right or bilateral brain damage. J Int Neuropsychol Soc 10:46–53
Hooper HE (1985) The Hooper Visual Organization Test. Manuel, Western Psychological Services, Los Angeles, CA
V.N. Benton AL, Hamsher KD (1978) Visuospatial judgment. A clinical test. Arch Neurol 35(6):364–367
Chan AS, Poon MW (1999) Performance of 7- to 95-year-old individuals in a Chinese version of the category fluency test. J Int Neuropsychol Soc 5:523–533
Johnston R, Jones K, Manley D (2018) Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour. Qual Quant 52(4):1957–1976
Elger CE, Grunwald T, Lehnertz K, Kutas M, Helmstaedter C, Brockhaus A, Van Roost D, Heinze HJ (1997) Human temporal lobe potentials in verbal learning and memory processes. Neuropsychologia 35(5):657–667
Moustafa AA, Chakravarthy S, Phillips JR, Crouse JJ, Gupta A, Frank MJ, Hall JM, Jahanshahi M (2016) Interrelations between cognitive dysfunction and motor symptoms of Parkinson’s disease: behavioral and neural studies. Rev Neurosci 27(5):535–548
Wojtala J, Heber IA, Neuser P, Heller J, Kalbe E, Rehberg SP, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen H-U, Riedel O, Dodel R, Schulz JB, Reetz K (2019) Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognition. J Neurol Neurosurg Psychiatry 90(2):171–179
Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65(8):1239–1245
Schillaci O, Chiaravalloti A, Pierantozzi M, Di Pietro B, Koch G, Bruni C, Stanzione P, Stefani A (2011) Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson’s disease at the early stages: molecular imaging with 123I-FP-CIT SPECT. Int J Mol Med 28(5):881–886
Domellöf ME, Elgh E, Forsgren L (2011) The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson’s disease. Mov Disord 26(12):2183–2189
Oh JY, Kim YS, Choi BH, Sohn EH, Lee AY (2009) Relationship between clinical phenotypes and cognitive impairment in Parkinson’s disease (PD). Arch Gerontol Geriatr 49(3):351–354
Burn DJ, Rowan EN, Allan LM, Molloy S, O’Brien JT, McKeith IG (2006) Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77(5):585–589
Moustafa AA, Krishna R, Eissa AM, Hewedi DH (2013) Factors underlying probabilistic and deterministic stimulus-response learning performance in medicated and unmedicated patients with Parkinson’s disease. Neuropsychology 27(4):498–510
Moustafa AA, Bell P, Eissa AM, Hewedi DH (2013) The effects of clinical motor variables and medication dosage on working memory in Parkinson’s disease. Brain Cogn 82(2):137–145
O’Reilly RC, Frank MJ (2006) Making working memory work: a computational model of learning in the prefrontal cortex and basal ganglia. Neural Comput 18(2):283–328
Rosenberg-Katz K, Herman T, Jacob Y, Giladi N, Hendler T, Hausdorff JM (2013) Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology 80(16):1476–1484
Elgh E, Domellöf M, Linder J, Edström M, Stenlund H, Forsgren L (2009) Cognitive function in early Parkinson’s disease: a population-based study. Eur J Neurol 16(12):1278–1284
Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76(3):343–348
Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain 130(Pt 7):1787–1798
Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA (2007) Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson’s disease. J Neurosci 27(18):4832–4838
de la Fuente-Fernández R (2012) Frontostriatal cognitive staging in Parkinson’s disease. Parkinsons Dis 2012:561046–561046
Puig MV, Antzoulatos EG, Miller EK (2014) Prefrontal dopamine in associative learning and memory. Neuroscience 282:217–229
Zgaljardic DJ, Borod JC, Foldi NS, Mattis PJ, Gordon MF, Feigin A, Eidelberg D (2006) An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson’s disease. J Clin Exp Neuropsychol 28(7):1127–1144
Fukaya C, Watanabe M, Kobayashi K, Oshima H, Yoshino A, Yamamoto T (2017) Predictive factors for long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease. Neurol Med Chir 57(4):166–171
Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment. Oxford University Press, UK
Schlösser R, Hutchinson M, Joseffer S, Rusinek H, Saarimaki A, Stevenson J, Dewey SL, Brodie JD (1998) Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry 64(4):492–498
Henry JD, Crawford JR (2004) Verbal fluency deficits in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc 10(4):608–622
Giussani C, Riva M, Gallucci M, Boukhatem L, Sganzerla EP, Demonet J-F, Roux F-E (2011) Anatomical correlates for category-specific naming of living and non-living things. Neuroimage 56(1):323–329
Cardona JF, Grisales-Cardenas JS, Trujillo-Llano C, Diazgranados JA, Urquina HF, Cardona S, Torres A, Torres LA, Gonzalez LM, Jaramillo T, Cediel J, Oñate-Cadena N, Mateus-Ferro G, Marmolejo-Ramos F (2021) Semantic memory and lexical availability in Parkinson’s disease: a statistical learning study. Front Aging Neurosci 13:697065–697065
Binder JR, Desai RH (2011) The neurobiology of semantic memory. Trends Cogn Sci 15(11):527–536
Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA (2003) The relationship between executive function and verbal memory in Parkinson’s disease. Brain Cogn 52(3):343–352
Bohlhalter S, Abela E, Weniger D, Weder B (2009) Impaired verbal memory in Parkinson disease: relationship to prefrontal dysfunction and somatosensory discrimination. Behav Brain Funct 5(1):49
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Ethical approval was obtained from the Hong Kong New Territories East Cluster Clinical Research Ethics Committee for the retrospective use of these clinical data. Written informed consent was obtained from each patient at pre-operation.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tang, V., Zhu, X.L., Lau, C. et al. Pre-operative cognitive burden as predictor of motor outcome following bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease. Neurol Sci 43, 6803–6811 (2022). https://doi.org/10.1007/s10072-022-06370-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06370-8